How to determine the optimal duration of anticoagulation for VTE: an evidence-based decision-analytical approach
Clinical Snapshot
PICO Framework
| P — Population | Patients with venous thromboembolism (VTE) requiring anticoagulation decisions |
| I — Intervention | Evidence-based decision-analytical framework for determining anticoagulation duration |
| C — Comparator | Current practice relying on physician intuition and guideline recommendations |
| O — Outcomes | Optimal anticoagulation duration recommendations incorporating patient values and preferences |
Bottom Line
This methodological paper presents a decision-analytical framework to systematically determine optimal VTE anticoagulation duration by transparently integrating evidence on benefits and harms with individual patient values. While the approach addresses a critical clinical need and offers theoretical advantages over current intuition-based practice, the abstract provides limited methodological detail and no validation data. The framework's practical utility will depend on implementation feasibility and whether it improves patient outcomes compared to existing approaches. Australian clinicians may find this framework valuable for structured decision-making, particularly given increasing emphasis on shared decision-making and patient-centred care. However, robust validation studies and practical implementation guidance are needed before widespread adoption.
Key Findings
Effect Size: Not applicable - methodological framework
Primary Outcome: Development of transparent decision-analytical framework for VTE anticoagulation duration
Nnt Or Sensitivity: Framework applied to three clinical scenarios: unprovoked VTE, travel-related VTE, and portal vein thrombosis
Confidence Interval: Not provided
Clinical Application
Requires training in decision-analytical methods and access to current evidence synthesis Highly relevant to Australian practice; aligns with RACGP patient-centred care principles and could inform PBS anticoagulant prescribing decisions All patients requiring VTE anticoagulation duration decisions across primary and specialist care
Abstract
When advising patients on the optimal duration of anticoagulation for venous thromboembolism (VTE), current management often relies on the intuition of treating physicians and guideline panels, an approach that remains opaque to outside observers. We present a decision-analytical framework adopted in our practice. This approach formalizes the intuition of physicians and guideline panels, providing an explicit and transparent integration of the best available evidence on benefits and harms. It also incorporates a systematic method for eliciting patient values and preferences to determine the optimal duration of anticoagulation. To demonstrate the practical utility of the decision-analytical approach, we apply it to 3 clinical scenarios: unprovoked VTE, VTE related to long-haul travel, and portal vein thrombosis in cirrhosis. By transparently synthesizing evidence and patient values, this method supports individualized, evidence-based, patient-centered recommendations for the duration of anticoagulation, and it is applicable to solving similar clinical problems in hematology and medicine.
Related Research
Human vaccines & immunotherapeutics
Artificial intelligence in immune checkpoint inhibitor research: A bibliometric analysis of the landscape
30 July 2026
Blood advances
Successful gene therapy for transfusion-dependent α-thalassemia: a case report
29 July 2026
Journal of chemical information and modeling
Functionally Guided Graph Learning for Robust Cross-Patient Cell-Type Annotation in Single-Cell RNA Sequencing
29 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service